KRChoksey Research has maintained its "BUY" recommendation for Aurobindo Pharma with a target price of Rs. 1,591, offering an upside potential of 33.5%.

Morningstar has reaffirmed its fair value estimate of $66 per share for Bristol-Myers Squibb (BMY), underscoring the company’s strong pipeline, wide economic moat, and solid financial position desp

Prabhudas Lilladher has reaffirmed a BUY rating for Sun Pharmaceutical Industries with a revised target price of Rs 2,275.

Prabhudas Lilladher has reaffirmed its BUY recommendation on Cipla, driven by the company's strong financial performance and strategic growth initiatives.

Natco Pharma has achieved a significant milestone with the approval from the United States Food and Drug Administration (USFDA) for its generic version of Everolimus tablets for oral suspen

Laurus Labs share price jumped by 4.5 percent on Friday as the company announced better-than-expected quarterly results.